非浸润性滤泡性肿瘤伴乳头状核特征(NIFTP)重新分类对恶性率的影响
该研究在单中心检索1046例有术前细胞学且切除后诊断为滤泡型甲状腺乳头状癌的病例,由内分泌病理学家重新评估NIFTP归类。重新分类后总体恶性率由31%降至29%,Bethesda各类别恶性率均有小幅下降,其中「可疑恶性」类别变化最明显(68%降至60%)。
要点
- NIFTP重新分类使总体恶性率仅小幅下降(31%至29%)。
- 「可疑恶性」Bethesda类别受影响最大,恶性率由68%降至60%。
- 多数NIFTP在细胞学/分子检测上仍为不确定病变,甲状腺切除术仍是常见处理方式。
核心结论
- 将非浸润性滤泡型甲状腺乳头状癌重新分类为NIFTP后,总体恶性率仅小幅下降。
- 受影响最大的Bethesda细胞学类别为「可疑恶性」。
- NIFTP分类主要影响决策,以避免过度治疗或过度监测。
研究设计与样本
- 单机构回顾性研究,检索1046例患者病历。
- 纳入有术前细胞学且切除后诊断为滤泡型甲状腺乳头状癌的病例,由内分泌病理学家复核以判定NIFTP重新分类。
主要发现
- 共识别60例(6%)滤泡型甲状腺乳头状癌,其中44例(4%)位于索引结节。
- 44例中84%(37例)符合评估标准,其中46%(17例)符合NIFTP标准。
- 重新分类后总体恶性率由31%变为29%。
- Bethesda各类别恶性率变化:良性(n=419)3.5%至3.3%;意义不明的异型性/意义不明的滤泡性病变(n=240)17%至15%;滤泡性肿瘤可疑(n=104)23%至21%;可疑恶性(n=85)68%至60%;恶性(n=198)93%至92%。
临床怎么用
- NIFTP重新分类对总体恶性率影响有限,临床决策仍需结合细胞学与分子检测综合判断。
- 因多数NIFTP在细胞学/分子检测上为不确定病变,甲状腺切除术仍是常见治疗方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The cytologic qualities of noninvasive follicular neoplasm with papillary-like nuclear features mimic papillary thyroid carcinoma (PTC) on fine-needle aspiration, leading to difficulty in distinguishing the 2 preoperatively. The aim of this study was to determine the impact of reclassification of noninvasive follicular neoplasm with papillary-like nuclear features at our practice. METHODS: We searched 1,046 patient charts for those cases with preoperative cytology and subsequent follicular-variant papillary thyroid carcinoma diagnosis on resection. Endocrine pathologists reviewed the cases to determine the reclassification of noninvasive follicular neoplasm with papillary-like nuclear features. RESULTS: Sixty (6%) follicular-variant papillary thyroid carcinomas were identified, 4% (44) in the index nodule. Of the 44 patients, 84% (37) met the criteria for evaluation. Of these, 46% (17) were noninvasive follicular neoplasm with papillary-like nuclear features. After reclassification of noninvasive follicular-variant papillary thyroid carcinoma to noninvasive follicular neoplasm with papillary-like nuclear features, the overall cancer rate changed from 31% to 29%. Malignancy rates across Bethesda cytologic categories changed as follows: benign (n = 419) from 3.5% to 3.3%; atypia of undetermined significance/follicular lesion of undetermined significance (n = 240) from 17% to 15%; suspicious for follicular neoplasm (n = 104) from 23% to 21%; suspicious for malignancy (n = 85) from 68% to 60%, and malignant (n = 198) from 93% to 92%. CONCLUSION: Reclassification of noninvasive follicular neoplasm with papillary-like nuclear features led to a small decrease in the overall malignancy rate. The most affected Bethesda category was suspicious for malignancy. Because the majority of noninvasive follicular neoplasm with papillary-like nuclear features will be indeterminate lesions by cytology/molecular testing, thyroidectomy will remain a common treatment modality. Noninvasive follicular neoplasm with papillary-like nuclear features classification will primarily affect decision making to avoid excessive treatment/monitoring.
引用
- Kiernan CM, Weiss VL, Mehrad M, et al. New terminology-noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP) and its effect on the rate of malignancy at a single institution. Surgery. 2017. PMID: 29126555. doi:10.1016/j.surg.2017.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。